HFNC for Induction During Bariatric Surgery Patients.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03155711|
Recruitment Status : Completed
First Posted : May 16, 2017
Last Update Posted : February 26, 2018
|Condition or disease||Intervention/treatment||Phase|
|Lung Collapse||Procedure: HFNC group Procedure: Standard group||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||64 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Study Protocol for the Use of High Flow Nasal Oxygen During the Anesthesia Induction and Weaning in Patients Scheduled for Bariatric Surgery. A Randomized Pilot Study|
|Actual Study Start Date :||May 5, 2017|
|Actual Primary Completion Date :||September 30, 2017|
|Actual Study Completion Date :||December 30, 2017|
HFNC with a 60 liters per minute flow will be given to the patients before anesthesia induction and before extubation at the end of the surgery
Procedure: HFNC group
Positive pressure plus supplemental oxygen through a high flow nasal oxygen device
Active Comparator: Standard
This patients will be managed as usual care. Pre-oxygenation before induction will be performed with supplemental oxygen but without positive pressure. After extubation patients will be oxygenated through a ventury mask.
Procedure: Standard group
Supplemental oxygen through venturi mask
- Oxygenation [ Time Frame: intraoperative ]The oxygenation (the ratio of partial pressure of arterial oxygen with inspiratory oxygen fraction, PaO2/FIO2) informs of the percentadge of shunt.
- Oxygenation [ Time Frame: First 24 postoperative hours ]PaO2/FIO2
- Atelectasis [ Time Frame: First 24 postoperative hours ]Atelectasis evaluated with X-ray
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03155711
|Hospital clínico universitario|
|Valencia, Spain, 46010|